发明名称 PROGESTERONE FORMULATIONS
摘要 This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters, in particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.
申请公布号 EP3122364(A1) 申请公布日期 2017.02.01
申请号 EP20150768772 申请日期 2015.03.27
申请人 TherapeuticsMD, Inc. 发明人 CACACE, Janice;PERSICANER, Peter;THORSTEINSSON, Thorsteinn;SANCILIO, Frederick;AMADIO, Julia;BERNICK, Brian
分类号 A61K31/57;A61K9/48;A61K47/30 主分类号 A61K31/57
代理机构 代理人
主权项
地址